Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Leaders for Veoneer and Autoliv announced ahead of planned spin-off

(Stockholm, Sweden, March 22, 2018) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, announces leaders for Veoneer, Inc. and Autoliv, Inc. ahead of the planned spin-off of Autoliv’s Electronics business, expected to be completed in the third quarter 2018.Jan Carlson will be the Chief Executive Officer of Veoneer following completion of the spin-off. Mr. Carlson will assume this role within the Veoneer business segment as of April 1, 2018 while continuing to serve in his role of Chairman, President and CEO of Autoliv until the spin-off.

ChromoGenics publishes the annual report 2017

ChromoGenics AB (publ) publishes the annual report 2017.ChromoGenics annual report for 2017, in Swedish and translated into English, is now available on  www.chromogenics.com/investors-partners/  in pdf-format. The annual report can also be ordered in print from the company and distributed via post to shareholders on demand. The Annual General Meeting will take place Wednesday May 16, 2018 at 14.00 CET in Advokatfirman Lindahl’s offices on Vaksalagatan 10, Uppsala. Complete notifications and documents will be available at www.chromogenics.

Option program for the CEO and the deputy CEO

Magnus Nilsson (CEO) has bought 400,000 options and Christoffer Rosenblad (deputy CEO and CFO) has bought 100,000 options via an option program issued by three large shareholders in XVIVO Perfusion AB. Each option gives the right to purchase one XVIVO Perfusion share during a two year period.The options are valued according to Black-Scholes and gives the right to purchase one XVIVO Perfusion share for SEK 124.00 within a two year period. XVIVO Perfusion AB (publ.) is not the contracting party of this transaction since the options are issued by three large shareholders. The Board of

Peptonic Medical’s VagiVital® close to CE mark

Stockholm, March 22nd, 2018 -  Peptonic Medical AB (publ) (’Peptonic’ or ’Company’) today announced that it has received the report of the evaluation of its so called Technical File.The evaluation has been performed by Lloyd’s Register Quality Assurance, Ltd. (LRQA) in England, acting as the Notified Body. The Company submitted the Technical File in January but due to a heavy work load at LRQA the evaluation report was delayed until now. The report lists a number of items of the Technical File that need clarification or need to be complemented. It is the view of the Company that these

Kamux Oyj: NOTICE TO THE ANNUAL GENERAL MEETING

Kamux Corporation   STOCK EXCHANGE RELEASE   22 March 2018 at 09:30 NOTICE TO THE ANNUAL GENERAL MEETING Notice is given to the shareholders of Kamux Corporation to the Annual General Meeting held on Thursday 26 April 2018 at 10 a.m. at Scandic Marina Congress Center, Nordia Hall, at address Katajanokanlaituri 6, 00160 Helsinki. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 9 a.m. A. Matters on the agenda of the Annual General Meeting 1. Opening of the meeting 2. Calling the meeting to order 3.

Revenio Group Corporation: The shares issued in Revenio Group Oyj's free share issue and other Annual General Meeting decisions have been entered to the trade register

Revenio Group Corporation, Stock Exchange Release, March 22, 2018 at 9.30 The shares issued in Revenio Group Oyj's free share issue and other Annual General Meeting decisions have been entered to the trade register. A total of 15.958.812 new shares issued in the free share issue decided upon in Revenio Group Oyj's Annual General Meeting on 20 March 2018 have been entered today in the trade register. The objective of the free share issue is to enhance the liquidity of the company's share. The free share issue applies the pre-emptive right of the shareholders, so that for each old share

Revenio Group Corporation: Notice pursuant to chapter 9, section 5 of the securities market act

Revenio Group Corporation, Stock Exchange Release, March 22, 2018 at 9.30 Notice pursuant to chapter 9, section 5 of the securities market act Revenio Group Corporation has March 21, 2018 received a notification of change in holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act that Joensuun Kauppa ja Kone Oy's share of the total number of shares and voting rights in Revenio Group Corporation has decreased to less than five per cent. Joensuun Kauppa ja Kone Oy now holds 1.056.600 shares in Revenio Group Corporation, which is 4.41 per cent of the company's

Stillfront: EMPIRE: Millennium Wars launches next week

PRESS RELEASE  March 22, 2018  EMPIRE: Millennium Wars launches next week on Android and iOS Goodgame Studios is proud to announce that its newest game, EMPIRE: Millennium Wars, will be launched globally next week on iOS and Android. The game is a new addition to Goodgame's portfolio under the EMPIRE brand, and will sit alongside EMPIRE and EMPIRE: Four Kingdoms. The first game under the EMPIRE brand was launched in 2011, and the EMPIRE brand has generated more than 880 million USD in user spend since. EMPIRE: Millennium Wars will provide a new and unique experience that will

Distributor from the South Korea on visit for demo of BERA 3.0

Last week, SensoDetect had the south Korean Distributor for a visit at our office in Lund to discuss further steps and to demonstrate the new BERA 3.0.The Distributor has previously shown great interest in cooperation on SensoDetects technology and introduction on the South Korean Market. As part of the continued negotiations, they visited the SensoDetects offices last week for a brief demonstration and concretisation of a plan for further negotiation with the aim of introducing SensoDetect on the market. The plan is now to, like the Sensodetects Strategy to first carry out a on-site trial

Welcome to the Annual General Meeting of Studsvik AB

Studsvik AB (publ), corporate identity number 556501-0997, gives notice to attend the Annual General Meeting to be held on Wednesday April 25, 2018 at 16.00 at the World Trade Center, Klarabergsviadukten 70/Kungsbron 1 in Stockholm. Registration for the Annual General Meeting starts at 15.00.Registration and notification of attendance Shareholders who wish to participate in the Annual General Meeting must · be registered in the share register kept by Euroclear Sweden AB by Thursday, April 19, 2018, and · give notification to the company by Thursday, April 19, 2018 at the latest.

Receipt of payment for KRI oil exports

22 March 2018 Genel Energy plc Receipt of payment for KRI oil exports Genel Energy plc ('Genel') notes the announcement from DNO ASA, as operator of the Tawke PSC, that the Tawke partners have received $62.46 million from the KRG as payment for December 2017 crude oil deliveries to the export market from the Tawke licence. Genel's net share of the payment is $15.62 million. The Company has received an override payment of $7.88 million from the KRG, representing 4.5% of Tawke gross licence revenues for the month of December 2017, as per the terms of the Receivable Settlement

Phase Holographic Imaging launches new website

Today Phase Holographic Imaging (PHI) launches a new website. The new website has been created to comprehensively provide extensive product information, as well as an introduction to the range of cell biology applications supported by the HoloMonitor® system.The new site provides improved navigation and has been designed using modern technology ensuring compliance with various browsers and mobile devices. Customers and other interested parties will easily find the benefits of HoloMonitor and its applications, as well as marketing- and product material, images and videos produced with

SEMCON AWARDED ROCKET OF THE YEAR AMONG SWEDEN’S MOST ATTRACTIVE EMPLOYERS

Semcon climbs eight places in the top 100 list of this year’s Business Barometer and is thereby named rocket of the year. Universum conducts the survey, in which engineering students rank Sweden’s most attractive employer.“It is gratifying to see that our work is appreciated by the engineers of the future. At Semcon, we work constantly to show potential employees what we represent. It is important that we live up to what we promise in the talent market, and the high commitment of our employees is an important piece of the puzzle in our credibility and attractiveness”, says Karin Russberg,

Stora Enso Wins Bio-Based Product of the Year for Lineo by Stora Enso

STORA ENSO OYJ PRESS RELEASE 22 March 2018 at 9.10 EETLineo™by Stora Enso, a renewable replacement for oil-based phenolic materials, has been awarded ‘Bio-Based Product of the Year’ at the Bio-Based World News Innovation Awards 2018. Shortlisted alongside products from Clean Plus Inc. and The Chemours Company, the judges recognised the potential of Lineo, made from versatile wood-based raw material lignin. Lineo can be used in a range of applications where fossil-based materials are currently used. Markus Mannström, Executive Vice President of the Stora Enso Biomaterials division,

Change in number of shares in Eyeonid Group AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on January 31st 2018.The number of Notes converted on March 21 2018 was 25. The number of Notes remaining under the first Tranche for future conversions is 120. The number of shares and the number of votes before the conversion was 51 122 887. Through the conversion, the number of shares and the number of votes have increased by 249 500. The total number of shares and the total number of votes after the conversion amount to 51 372 387. For terms and conditions of the

NOTICE OF ANNUAL GENERAL MEETING

Shareholders of Addnode Group Aktiebolag (publ) (“Addnode Group”) are hereby invited to attend the Annual General Meeting on Thursday, 26 April 2018, at 6:00 p.m. at Westmanska Palatset, Holländargatan 17. Doors will open at 5.00 p.m.REGISTRATION To be entitled to participate in the Annual General Meeting, shareholders must be listed in the register of shareholders maintained by Euroclear Sweden AB, on Friday, 20 April 2018, and inform the Company of their intention to attend no later than Friday, 20 April 2018, by post to Addnode Group Aktiebolag (publ), “Annual General Meeting,”

BerGenBio to present overview of phase II clinical trial portfolio combining bemcentinib with KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe

Bergen, Norway, 22 March 2018 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors as a potential cornerstone of combination cancer therapy, announces that the Company will be presenting an overview of the three ongoing phase II trials combining the Company’s selective AXL inhibitor bemcentinib with the anti-PD-1 therapy KEYTRUDA at the 3rd Annual Immuno-Oncology Summit Europe, London, UK, today at 10:05-10:35 GMT.The presentation will be delivered by Dr. Julia Schoelermann, Assoc. Director Business Development &

Attendo publishes the Annual Report for 2017

Today Attendo has released its Annual Report for the calendar year 2017.The Annual Report 2017 can be downloaded from www.attendo.com. Attendo AB (publ) For further information, please contact: Andreas Koch, Communications and IR-Director AttendoPhone: +46 705 09 77 61E-mail: andreas.koch@attendo.com This information is such that Attendo AB (publ) is required to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the Communication and IR-Director, on 22 March 2018 at 08.00 CET. ________________

Bonava acquires land outside Copenhagen

Bonava has concluded an agreement for the acquisition of land from the Municipality of Greve outside Copenhagen at a price of approximately SEK 95 million. There are plans to build about 122 apartments and 134 single-family houses in the area. The project is scheduled to start in the second quarter of 2019 and the first residents are expected to move in during the fourth quarter of 2020.- The acquisition is in line with our strategy to increase our market share in Copenhagen and the surrounding area. Greve is an attractive area where we can play a part in continuing to develop happy

Notification of Annual General Meeting

Shareholders of Catena AB (publ) are hereby invited to attend the Annual General Meeting Thursday, 26 April 2018 at 4:00 p.m., at the IVA conference centre, Grev Turegatan 16 in Stockholm, Sweden.22 March 2018, 8:00 a.m.  Shareholders wishing to attend the Meeting must be recorded in the share register maintained by Euroclear Sweden AB on Friday, 20 April 2018, and shall have e-mailed notification of their intention to participate and any assistants to ulrika.holmer@catenafastigheter.se by Friday, 20 April 2018, 2:00 p.m. at the latest. Notification can also be provided by telephone on

Orexo publishes the Annual Report for 2017

Uppsala, Sweden - March 22, 2018 – Orexo’s Annual Report for the 2017 fiscal year has been published and can be downloaded on the company’s website, www.orexo.com (investors/reports, presentations and audiocasts). This year, a Sustainability Report is included in the Annual Report. For further information, please contact: Orexo AB (publ.) Lena Wange, IR & Communications ManagerTel: +46 18 780 88 00E-mail: ir@orexo.com About OrexoOrexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but

Samhällsbyggnadsbolaget i Norden AB has repurchased bonds

Samhällsbyggnadsbolaget i Norden AB (“SBB”) today announces a repurchase of bonds with a nominal value of SEK 124,000,000. This repurchase of bonds relates to unsecured bonds issued by the subsidiary SBB i Norden AB (publ) with a nominal outstanding amount of SEK 600,000,000, including already repurchased bonds by SBB. The bonds have a floating rate corresponding to STIBOR 3m plus 6.25 percent and are due in June 2018 (ISIN: SE0009470115). The purchase price corresponds to 101.50 percent of the remaining outstanding nominal value of the bonds, i.e. approx. SEK 125,860,000. Following the

Samhällsbyggnadsbolaget i Norden AB has repurchased bonds

Samhällsbyggnadsbolaget i Norden AB (“SBB”), parent company of SBB i Norden AB (publ), today announces a repurchase of bonds with a nominal value of SEK 124,000,000. This repurchase of bonds relates to unsecured bonds issued by the subsidiary SBB i Norden AB (publ) with a nominal outstanding amount of SEK 600,000,000, including already repurchased bonds by SBB. The bonds have a floating rate corresponding to STIBOR 3m plus 6.25 percent and are due in June 2018 (ISIN: SE0009470115). The purchase price corresponds to 101.50 percent of the remaining outstanding nominal value of the bonds, i.e.

Attendo publishes Annual Quality and Sustainability Report for 2017

Today Attendo has released its Annual Report for 2017. A new Annual Quality and Sustainability Report has also been released to show how Attendo contributes to the development of society in important areas.- We want to show the most important challenges to society in care and health care and how Attendo actively is contributing to meet the demand for more beds in modern nursing homes in the Nordics. The fact that we have opened around one in every four new beds in care for older people over the last five years in Finland and Sweden clearly show that Attendo plays a key part in how society

There are no items matching the current filter
There are no more items matching the current filter
Back to top